Weight loss drugs have revolutionized the treatment of obesity, but their high price has put them out of reach for many Americans. Eli Lilly is trying to bring the cost down a bit. The company that makes drugs like Mounjaro and Zepbound just announced that it has launched single-dose vials of the latter. As a […]
Weight loss drugs have revolutionized the treatment of obesity, but their high price has put them out of reach for many Americans. Eli Lilly is trying to bring the cost down a bit. The company that makes drugs like Mounjaro and Zepbound just announced that it has launched single-dose vials of the latter. As a […]
Until now, Zepbound has been packaged in a single device, an injection pen that contains both the medication and the needle. Patients press a button on one end to insert a needle on the other end, which delivers the dose. With the new vials, patients use a syringe to draw up their dose and then […]
Deutsche Bank has issued an optimistic forecast for Eli Lilly (LLY) and raised the pharmaceutical stock’s rating from “Hold” to “Buy.” The price target was raised by $300 to a total of $1,025 per share. James Shin, an analyst at Deutsche Bank, explains the pharmaceutical company’s forecast and outlook at Catalysts. Shin says the biggest […]
